Cosaic secures $6 million seed extension as industry leaders back next-generation food ingredients

Zurich, Switzerland, April 21, 2026 -- Cosaic, the Swiss food biotech startup developing yeast-derived multifunctional ingredients, today announced a $6 million round. The round includes participation from dsm-firmenich Ventures, the venture arm of dsm-firmenich, a global leader in Health, Nutrition and Beauty. Also joining the round are a large Swiss family office and Kickfund, a Swiss deeptech investor, as well as existing investors such as Navus Ventures and Zuercher Kantonalbank. In a tougher funding environment, this round shows that investors continue to support foodtech companies when the technology is distinctive and the commercialization plan is realistic.

Cosaic is developing a new category of food ingredients based on yeast fermentation. Its platform is designed to help food and beverage manufacturers deliver creaminess, stability, and functionality in a single ingredient, addressing formulation challenges that have traditionally required multiple components and additives. This investment signals growing industry interest in ingredient platforms that move beyond one-to-one replacement narratives and instead offer measurable functional value to manufacturers.

The round will support three priorities over the coming phase of growth to become market ready: regulatory work, production scale-up, and industrial trials with large clients.

"This round sends a clear signal: the market is backing foodtech companies that can deliver real functional value and a credible path to commercialization," said Tomas Turner, co-founder and CEO of Cosaic. "At Cosaic, we are building an ingredient that resolves the trade-offs food companies face every day between clean label, sensory performance, and cost. With strong strategic backing and a capital-efficient scale-up model, we are well positioned to move from development to launch readiness."

The announcement follows Cosaic’s strategic go-to-market partnership with another leading ingredient house, Ingredion, announced in late 2025, which provided the company with important commercial validation. With backing from Ingredion and dsm-firmenich Ventures, Cosaic is now accelerating the path from product development to market launch.

About Cosaic (formerly known as Cultivated Biosciences)

Cosaic is a Swiss biotech and foodtech startup that aims for a world in which good food choices benefit everyone: people, businesses, and the planet. They do this with ingredient solutions that offer greater industry resilience and greater consumer satisfaction. Cosaic Neo is their first ingredient, a unique natural multifunctional emulsion that delivers perfect stability and delicious creaminess, all at once, by itself. It is a patented food ingredient born from yeast fermentation. Its complex microstructure allows for multiple functionalities to reconcile product performance with sensory experience while cleaning labels. Cosaic employs 15 people and is in pre-series A stage, preparing for a market entry next year in the US. More info: www.cosaic.bio